Medicare Enrolled
Dr. Danny Bartel, M.D.
Neurology · Wichita Falls, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bartel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bartel? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bartel
Dr. Danny Bartel is a neurology in Wichita Falls, TX, with 20 years in practice. Based on federal Medicare data, Dr. Bartel performed 100,172 Medicare services across 7,598 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bartel received a total of $45,252 from 83 pharmaceutical and/or device companies across 1969 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bartel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 1% volume in TX$ $45,252 industry payments
Medicare Practice Summary
Medicare Utilization ↗100,172
Medicare services
Top 1% in TX for neurology
7,598
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,009 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, natalizumab, 1 mg | 39,600 | $19 | $48 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 28,808 | $53 | $76 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 12,158 | $38 | $101 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 6,079 | $97 | $143 |
| Office visit, established patient (30-39 min) | 2,955 | $94 | $311 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 2,580 | $76 | $261 |
| Dexamethasone injection (steroid) | 840 | $0 | $0 |
| Nerve conduction, 13 or more studies | 643 | $221 | $851 |
| Steroid injection (triamcinolone) | 582 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 563 | $15 | $33 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 491 | $48 | $113 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 390 | $329 | $1,409 |
| Telephone medical discussion with physician, 11-20 minutes | 304 | $65 | $150 |
| Office visit, established patient (20-29 min) | 277 | $65 | $210 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 276 | $4 | $11 |
| Injection, methylprednisolone acetate, 40 mg | 266 | $6 | $11 |
| Injection into tendon or ligament | 265 | $31 | $171 |
| New patient office visit (45-59 min) | 223 | $117 | $477 |
| Testing of autonomic (sympathetic) nervous system function | 217 | $89 | $255 |
| Ultrasound study of arm and leg arteries | 184 | $49 | $174 |
| Testing of autonomic nervous system function and heart rate response to deep breathing | 181 | $56 | $172 |
| Ultrasound of both sides of head and neck blood flow | 170 | $110 | $450 |
| Complete ultrasound of within the brain blood flow | 170 | $161 | $570 |
| Test or measurement for functional capacity, each 15 minutes | 170 | $25 | $85 |
| Ultrasound of within the brain blood flow following medication | 169 | $213 | $600 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 167 | $25 | $95 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 161 | $274 | $570 |
| Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report | 160 | $61 | $212 |
| Injection of substance into lower spine canal | 147 | $106 | $633 |
| Test for balance and posture | 138 | $36 | $170 |
| Evaluation and testing for balance with recording | 128 | $76 | $173 |
| Test for abnormal eye movement using a rotating chair | 127 | $91 | $170 |
| Injection of substance into middle or upper spine canal | 113 | $123 | $689 |
| Test to assess balance during warm and cool irrigation in both ears | 107 | $28 | $69 |
| Injection of additional new drug or substance into vein | 73 | $12 | $40 |
| Measurement of nerve conduction using visual stimulation testing with report | 61 | $49 | $215 |
| Injection, diphenhydramine hcl, up to 50 mg | 37 | $1 | $2 |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 36 | $0 | $15 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 35 | $259 | $1,172 |
| Injection of drug or substance into vein | 33 | $26 | $100 |
| Administration of chemotherapy into vein, 1 hour or less | 31 | $88 | $153 |
| Joint injection, major joint | 20 | $41 | $175 |
| Aspiration and/or injection of fluid from medium joint | 19 | $34 | $145 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 18 | $55 | $226 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
55.5% medium
43.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$45,252
Total received (2018-2024)
Avg $6,465/year across 7 years
Top 10% in TX for neurology
83
Companies
1,969
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,065 (66.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,532 (18.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,655 (14.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,048
2023$5,365
2022$4,776
2021$4,465
2020$18,771
2019$3,928
2018$3,899
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Allergan, Inc.
$8,066
EMD Serono, Inc.
$7,565
Supernus Pharmaceuticals, Inc.
$2,989
Biogen, Inc.
$2,639
ACADIA Pharmaceuticals Inc
$1,935
Novartis Pharmaceuticals Corporation
$1,706
GENZYME CORPORATION
$1,260
Neurocrine Biosciences, Inc.
$1,093
Alexion Pharmaceuticals, Inc.
$1,023
Teva Pharmaceuticals USA, Inc.
$1,011
Sunovion Pharmaceuticals Inc.
$998
Celgene Corporation
$922
UCB, Inc.
$783
Mallinckrodt Hospital Products Inc.
$695
Abbott Laboratories
$694
Kyowa Kirin, Inc.
$544
AbbVie Inc.
$543
LivaNova USA, Inc.
$542
PFIZER INC.
$541
SK Life Science, Inc.
$501
ABBVIE INC.
$489
ARGENX US, INC.
$482
Horizon Therapeutics plc
$474
Harmony Biosciences LLC
$450
Genentech USA, Inc.
$441
Amgen Inc.
$427
Acorda Therapeutics, Inc
$416
Sumitomo Pharma America, Inc.
$335
CSL Behring
$301
Currax Pharmaceuticals LLC
$297
Radius Health, Inc.
$286
ANI Pharmaceuticals, Inc.
$283
Upsher-Smith Laboratories LLC
$272
Grifols USA, LLC
$269
Takeda Pharmaceuticals U.S.A., Inc.
$261
Eisai Inc.
$260
REVANCE THERAPEUTICS, INC.
$256
Lundbeck LLC
$191
Lilly USA, LLC
$179
MITSUBISHI TANABE PHARMA AMERICA, INC.
$160
Avanir Pharmaceuticals, Inc.
$159
Daiichi Sankyo Inc.
$155
Corium, LLC
$153
US WorldMeds, LLC
$152
Ipsen Biopharmaceuticals, Inc
$148
Almatica Pharma LLC
$144
Biohaven Pharmaceutical Holding Company Ltd.
$131
Biohaven Pharmaceuticals, Inc.
$124
E.R. Squibb & Sons, L.L.C.
$114
NEUROPACE, INC.
$102
Merz Pharmaceuticals, LLC
$101
GE HealthCare
$88
Exeltis, USA Inc.
$82
TG Therapeutics, Inc.
$70
MDD US Operations, LLC
$64
Xeris Pharmaceuticals, Inc.
$63
Sentynl Therapeutics, Inc.
$60
Purdue Pharma L.P.
$54
Axsome Therapeutics, Inc.
$51
UPSHER-SMITH LABORATORIES LLC
$48
Octapharma USA, Inc.
$46
Collegium Pharmaceutical, Inc.
$44
Adamas Pharmaceuticals, Inc.
$44
GlaxoSmithKline, LLC.
$43
Medtronic USA, Inc.
$38
Mitsubishi Tanabe Pharma America, Inc.
$35
EISAI INC.
$34
BOSTON SCIENTIFIC CORPORATION
$32
Neurelis, Inc.
$30
Strongbridge US INC.
$30
SI-BONE, Inc.
$30
Allergan Inc.
$27
AbbVie, Inc.
$23
Janssen Pharmaceuticals, Inc
$19
Otsuka America Pharmaceutical, Inc.
$19
Amneal Pharmaceuticals LLC
$18
SCILEX PHARMACEUTICALS INC.
$17
CATALYST PHARMACEUTICALS, INC.
$15
GE HEALTHCARE
$15
Retrophin, Inc.
$14
JAZZ PHARMACEUTICALS INC.
$13
Pernix Therapeutics Holdings, Inc.
$12
IMPEL PHARMACEUTICALS INC.
$12
Top 3 companies account for 41.1% of total payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Apokyn · Austedo XR · BENLYSTA · BOTOX · BRIUMVI · Briviact · COMIRNATY · CONTRAVE · COPAXONE · DAXXIFY · DUOPA · Dysport · EMGALITY · Entyvio · FIRDAPSE · FORTEO · Fintepla · Fycompa · GILENYA · GOCOVRI · GRALISE · GVOKE PFS · Gamunex-C · Hizentra · INBRIJA · INFINITY · INGREZZA · INJECTAFER · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LEQEMBI · LYRICA · Leqembi · Levorphanol Tartrate · Lucemyra/Lofexidine · MAYZENT · MYOBLOC · Mavenclad · Morphabond ER · Movantik · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONZETRA XSAIL · ONZETRA Xsail · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qelbree · RADICAVA · REXULTI · RNS Neurostimulator Kit · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SYMPROIC · Soliris · Solitaire · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trintellix · Trudhesa · Tymlos · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XCOPRI · XTAMPZA · XYREM · Xadago · Xeomin · Xtampza ER · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOHYDRO ER · ZTLido · Zembrace SymTouch Sumatriptan Injection · Zinbryta · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for neurology in TX.
Equivalent to $45 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
7
Per 100K population
5.4
County median income
$62,168
Nearest hospital
UNITED REGIONAL HEALTH CARE SYSTEM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bartel is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (low-engagement, top 10%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bartel experienced with injection, natalizumab, 1 mg?
Based on Medicare claims data, Dr. Bartel performed 39,600 injection, natalizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bartel receive payments from pharmaceutical companies?
Yes. Dr. Bartel received a total of $45,252 from 83 companies across 1,969 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bartel's costs compare to other neurologys in Wichita Falls?
Dr. Bartel's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bartel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Wichita Falls
Browse neurologys in Wichita Falls ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in TX
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in TX
Which TX neurologys receive the most from drug and device companies.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc..
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc..
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology